Disease and Therapy Review Ovarian Cancer

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Nov 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Key Pharma News 17 NOVEMBER 2014

Key Pharma News 17 NOVEMBER 2014

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 29 pages

Industry Trend Analysis - Conference Reveals Future Diversification Of HCV Market Industry Brief - Intarcia/Servier Sign Ex-US Partnership For ITCA 650 In Diabetes Industry Brief - Genmab Transfers Ofatumumab Collaboration From GSK To Novartis Industry Trend Analysis - Merck Places Confidence In Accurin ...

Industries: Pathology | Countries: Luxembourg, Germany, Belgium

UMMC - Marlene and Stewart Greenebaum Cancer Center Expansion - Maryland - Construction Project Profile

UMMC - Marlene and Stewart Greenebaum Cancer Center Expansion - Maryland - Construction Project Profile

  • $ 75
  • Company report
  • by World Market Intelligence Ltd
  • November 2014
  • 8 pages

Synopsis The "UMMC - Marlene and Stewart Greenebaum Cancer Center Expansion - Maryland" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, ...

Industries: Pathology | Countries: United States

MoH - Baghdad Cancer Hospital - Iraq - Construction Project Profile

MoH - Baghdad Cancer Hospital - Iraq - Construction Project Profile

  • $ 75
  • Company report
  • by World Market Intelligence Ltd
  • November 2014
  • 8 pages

Synopsis The "MoH - Baghdad Cancer Hospital - Iraq" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. ...

Industries: Pathology | Countries: Iraq

MolecularMD, Corp. - Product Pipeline Analysis, 2014 Update

MolecularMD, Corp. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • November 2014
  • 30 pages

Summary MolecularMD, Corp. (MolecularMD) is a biotechnology company. The company carries out the development and commercialization of specialty molecular diagnostics for oncology applications and cancer therapies. Its key technologies include droplet digital PCR (ddPCR) and next-generation sequencing ...

Industries: Pathology | Countries: United States

Mumps - Pipeline Review, H2 2014

Mumps - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 38 pages

Mumps - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Mumps - Pipeline Review, H2 2014', provides an overview of the Mumps's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mumps, complete with comparative analysis at various stages, ...

Industries: Pathology | Countries: World, China

Friedreich Ataxia - Pipeline Review, H2 2014

Friedreich Ataxia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 81 pages

Friedreich Ataxia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Friedreich Ataxia - Pipeline Review, H2 2014', provides an overview of the Friedreich Ataxia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Friedreich Ataxia, complete ...

Industries: Pathology | Countries: World

Cataract - Pipeline Review, H2 2014

Cataract - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 46 pages

Cataract - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Cataract - Pipeline Review, H2 2014', provides an overview of the Cataract's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cataract, complete with comparative analysis at ...

Industries: Pathology | Countries: World

Arterial Thrombosis - Pipeline Review, H2 2014

Arterial Thrombosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 56 pages

Arterial Thrombosis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Arterial Thrombosis - Pipeline Review, H2 2014', provides an overview of the Arterial Thrombosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Arterial Thrombosis, ...

Industries: Pathology | Countries: World

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2014

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 70 pages

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2014', provides an overview of the Neuromyelitis Optica (Devic's Syndrome)'s therapeutic pipeline. This report provides comprehensive information ...

Industries: Pathology | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.